Ticker
ESPRCompany Name
ESPERION THERAPEUTICS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 391.15M | $ 3.33M | $ 0 | -0.85% |
3/31/2025 | $ 176.99M | $ 9.55M | $ 0 | -5.4% |
12/31/2024 | $ 334.36M | $ 105.99M | $ 0 | -31.7% |
9/30/2024 | $ 415.74M | $ 115.11M | $ 0 | -27.69% |
6/30/2024 | $ 361.05M | $ 114.55M | $ 0 | -31.73% |
3/31/2024 | $ 449.02M | $ 109.78M | $ 0 | -24.45% |
12/31/2023 | $ 536.65M | $ 65.94M | $ 0 | -12.29% |
9/30/2023 | $ 117.13M | $ 78.86M | $ 0 | -67.33% |
6/30/2023 | $ 180.82M | $ 127.55M | $ 0 | -70.54% |
3/31/2023 | $ 134.49M | $ 143.45M | $ 0 | -106.66% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for ESPERION THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 13.41M ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 808.14M ]
(=) Payout Yield [ -1.66% ]
Minimum
Mar 31, 2023
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.1% |